# Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-albuminuric-effect-of-the-aldosterone-blocker-eplerenone-in-non-diabetic/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Katsuyuki Ando,Hiroshi Ohtsu,Shunya Uchida,Shinya Kaname,Yoshihiro Arakawa,Toshiro Fujita |
| Citations | 126 |
| DOI | 10.1016/s2213-8587(14)70194-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2094672734 |
| PMID | 25466242 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Shunya Uchida](https://scholariq.org/researchers/shunya-uchida/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)

## Paper topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.